title: Human labour is associated with decreased cytoplasmic FoxO4.
abstract: Forkhead box O (FoxO) proteins function primarily as transcription factors in the nucleus where they bind to their cognate DNA targeting sequences. FoxO regulated genes include those involved in cellular stress responses, inflammation and apoptosis; all of which are involved in the processes of human labour and delivery. We have previously identified Forkhead box O4 (FoxO4) proteins in human gestational tissues; there is, however, no data is available on the role of FoxO4 in the processes of human labour and delivery. Thus the aim of this study was to determine the effect of (i) human labour, preterm chorioamnionitis and pro-inflammatory stimuli on the expression of FoxO4 in human placenta and fetal membranes; and (ii) FoxO4 knockdown by siRNA on the expression of pro-labour mediators. Quantitative RT-PCR (qRT-PCR), immunohistochemistry and/or Western blotting was used to analyse the expression of FoxO4 (n = 6 per group). Human labour and preterm chorioamnionitis significantly decreased cytoplasmic FoxO4 expression in placenta and/or choriodecidua. Knockdown of FoxO4 mRNA and protein in JEG-3 cells using siRNA was associated with decreased COX-2 mRNA expression concomitant with lower PGF(2α) secretion. However, in BeWo cells, siRNA inhibition of FoxO4 was not associated with inflammation, oxidative stress or apoptosis. In summary, human term labour and chorioamnionitis is characterised by lower FoxO4 mRNA and/or protein expression in placenta and/or choriodecidua. Although the exact role of FoxO4 in human pregnancy remains to be fully elucidated, our data demonstrate that it can regulate COX-2 expression and subsequent prostaglandin expression.
authors: Department of Obstetrics and Gynaecology, University of Melbourne, Victoria, Australia.
authors: R
authors: R
authors: Lim
authors: C
authors: C
authors: Riley
authors: G
authors: G
authors: Barker
authors: G E
authors: GE
authors: Rice
authors: M
authors: M
authors: Lappas
mesh_terms: D000328:Adult; D017209:Apoptosis; D018797:Cell Cycle Proteins; D002460:Cell Line; D002821:Chorioamnionitis / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D051546:Cyclooxygenase 2 / Q000235:genetics / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism; D003593:Cytoplasm / Q000378:metabolism*; D003656:Decidua / Q000166:cytology / Q000276:immunology / Q000378:metabolism / Q000473:pathology; D015237:Dinoprost / Q000378:metabolism; D015536:Down-Regulation; D005321:Extraembryonic Membranes / Q000166:cytology / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D005260:Female; D051858:Forkhead Transcription Factors; D020868:Gene Silencing; D006801:Humans; D007743:Labor, Obstetric / Q000378:metabolism; D036801:Parturition / Q000378:metabolism*; D010920:Placenta / Q000166:cytology / Q000276:immunology / Q000378:metabolism* / Q000473:pathology; D011247:Pregnancy; D011257:Pregnancy Proteins / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*; D012333:RNA, Messenger / Q000378:metabolism; D034741:RNA, Small Interfering; D014157:Transcription Factors / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*
chemical_list: D018797:Cell Cycle Proteins; D016207:Cytokines; C108803:FOXO4 protein, human; D051858:Forkhead Transcription Factors; D011257:Pregnancy Proteins; D012333:RNA, Messenger; D034741:RNA, Small Interfering; D014157:Transcription Factors; D015237:Dinoprost; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human